SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-004897
Filing Date
2017-03-21
Accepted
2017-03-21 16:08:07
Documents
65
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abio-10k_20161231.htm 10-K 2147579
2 EX-10.58 abio-ex1058_61.htm EX-10.58 146581
3 EX-23.1 abio-ex231_8.htm EX-23.1 3037
4 EX-31.1 abio-ex311_6.htm EX-31.1 14987
5 EX-31.2 abio-ex312_7.htm EX-31.2 16097
6 EX-32.1 abio-ex321_9.htm EX-32.1 9341
  Complete submission text file 0001564590-17-004897.txt   6847956

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abio-20161231.xml EX-101.INS 1310667
8 XBRL TAXONOMY EXTENSION SCHEMA abio-20161231.xsd EX-101.SCH 44894
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20161231_cal.xml EX-101.CAL 45259
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20161231_def.xml EX-101.DEF 139317
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20161231_lab.xml EX-101.LAB 408794
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20161231_pre.xml EX-101.PRE 293476
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 17704283
SIC: 2835 In Vitro & In Vivo Diagnostic Substances